BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, Mowat AP, Vergani D, Mieli-Vergani G. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology. 1997;25:541-547. [PMID: 9049195 DOI: 10.1002/hep.510250308] [Cited by in Crossref: 428] [Cited by in F6Publishing: 319] [Article Influence: 17.8] [Reference Citation Analysis]
Number Citing Articles
1 Muratori P, Lalanne C, Fabbri A, Cassani F, Lenzi M, Muratori L. Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype. Aliment Pharmacol Ther 2015;41:1281-7. [DOI: 10.1111/apt.13210] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
2 Vierling JM, Flores PA. Evolving new therapies of autoimmune hepatitis. Clin Liver Dis 2002;6:825-50, ix. [PMID: 12362583 DOI: 10.1016/s1089-3261(02)00029-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
3 Krawitt EL. Can you recognize autoimmune hepatitis? Postgrad Med 1998;104:145-9, 152. [PMID: 9721584 DOI: 10.3810/pgm.1998.08.563] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
4 Woynarowski M, Nemeth A, Baruch Y, Koletzko S, Melter M, Rodeck B, Strassburg CP, Pröls M, Woźniak M, Manns MP. Budesonide versus Prednisone with Azathioprine for the Treatment of Autoimmune Hepatitis in Children and Adolescents. The Journal of Pediatrics 2013;163:1347-1353.e1. [DOI: 10.1016/j.jpeds.2013.05.042] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 7.9] [Reference Citation Analysis]
5 Longhi MS, Meda F, Wang P, Samyn M, Mieli-Vergani G, Vergani D, Ma Y. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis. Hepatology. 2008;47:581-591. [PMID: 18220288 DOI: 10.1002/hep.22071] [Cited by in Crossref: 90] [Cited by in F6Publishing: 74] [Article Influence: 6.9] [Reference Citation Analysis]
6 Liberal R, Selmi C, Gershwin ME. Diego and Giorgina Vergani: The two hearts of translational autoimmunity. Journal of Autoimmunity 2016;66:1-6. [DOI: 10.1016/j.jaut.2015.11.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
7 Wang G, Tanaka A, Zhao H, Jia J, Ma X, Harada K, Wang FS, Wei L, Wang Q, Sun Y, Hong Y, Rao H, Efe C, Lau G, Payawal D, Gani R, Lindor K, Jafri W, Omata M, Sarin SK. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int 2021;15:223-57. [PMID: 33942203 DOI: 10.1007/s12072-021-10170-1] [Reference Citation Analysis]
8 Nunes MEG, Rosa DV, Fagundes EDT, Ferreira AR, Miranda DMD, Ferri Liu PM. HLA-DRB1 GENE POLYMORPHISMS IN PEDIATRIC PATIENTS WITH TYPE 1 AUTOIMMUNE HEPATITIS AND TYPE 1 AUTOIMMUNE HEPATITIS OVERLAP SYNDROME WITH AUTOIMMUNE CHOLANGITIS. Arq Gastroenterol 2019;56:146-50. [DOI: 10.1590/s0004-2803.201900000-29] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Banerjee S, Rahhal R, Bishop WP. Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis. J Pediatr Gastroenterol Nutr. 2006;43:353-356. [PMID: 16954959 DOI: 10.1097/01.mpg.0000232331.93052.dd] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
10 Czaja AJ. Evolving paradigm of treatment for autoimmune hepatitis. Expert Review of Clinical Immunology 2017;13:781-98. [DOI: 10.1080/1744666x.2017.1319764] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Abdalla AF, Zalata KR, Ismail AF, Shiha G, Attiya M, Abo-Alyazeed A. Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods. Fibrogenesis Tissue Repair. 2009;2:2. [PMID: 19341455 DOI: 10.1186/1755-1536-2-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
12 Moy L, Levine J. Autoimmune hepatitis: a classic autoimmune liver disease. Curr Probl Pediatr Adolesc Health Care. 2014;44:341-346. [PMID: 25466500 DOI: 10.1016/j.cppeds.2014.10.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
13 Al-Busafi SA, Michel RP, Deschenes M. Rituximab for refractory autoimmune hepatitis: a case report. Arab J Gastroenterol. 2013;14:135-138. [PMID: 24206745 DOI: 10.1016/j.ajg.2013.08.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
14 Bortolotti F, Muratori L, Jara P, Hierro L, Verucchi G, Giacchino R, Barbera C, Zancan L, Guido M, Resti M, Pedditzi S, Bianchi F, Gatta A. Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children. The Journal of Pediatrics 2003;142:185-90. [DOI: 10.1067/mpd.2003.45] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
15 Czaja AJ, Shums Z, Norman GL. Nonstandard Antibodies as Prognostic Markers in Autoimmune Hepatitis. Autoimmunity 2009;37:195-201. [DOI: 10.1080/08916930410001702469] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
16 Vogel A, Heinrich E, Bahr MJ, Rifai K, Flemming P, Melter M, Klempnauer J, Nashan B, Manns MP, Strassburg CP. Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant. 2004;18:62-69. [PMID: 15108772 DOI: 10.1111/j.1399-0012.2004.00117.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 72] [Article Influence: 6.0] [Reference Citation Analysis]
17 Williams R. EASL Recognition Award Recipient 2017: Prof. Giorgina Mieli-Vergani. Journal of Hepatology 2017;66:878-81. [DOI: 10.1016/j.jhep.2016.12.013] [Reference Citation Analysis]
18 Strassburg CP. Autoimmune hepatitis. Best Pract Res Clin Gastroenterol 2010;24:667-82. [PMID: 20955969 DOI: 10.1016/j.bpg.2010.07.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
19 Bernal W, Ma Y, Smith HM, Portmann B, Wendon J, Vergani D. The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol. 2007;47:664-670. [PMID: 17602781 DOI: 10.1016/j.jhep.2007.05.011] [Cited by in Crossref: 71] [Cited by in F6Publishing: 53] [Article Influence: 5.1] [Reference Citation Analysis]
20 de Boer YS, Liberal R, Vergani D, Mieli-Vergani G. Real-world management of juvenile autoimmune liver disease. United European Gastroenterol J 2018;6:1032-8. [PMID: 30228891 DOI: 10.1177/2050640618768922] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Debray D, Maggiore G, Girardet JP, Mallet E, Bernard O. Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis. J Pediatr. 1999;135:111-114. [PMID: 10393616 DOI: 10.1016/s0022-3476(99)70339-2] [Cited by in Crossref: 76] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
22 Kanzler S, Gerken G, Löhr H, Galle PR, Meyer zum Büschenfelde KH, Lohse AW. Duration of immunosuppressive therapy in autoimmune hepatitis. J Hepatol 2001;34:354-5. [PMID: 11281572 DOI: 10.1016/s0168-8278(00)00095-7] [Cited by in Crossref: 77] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
23 Maia JM, Maranhão Hde S, Sena LV, Rocha LR, Medeiros IA, Ramos AM. Hepatic stellate cell activation and hepatic fibrosis in children with type 1 autoimmune hepatitis: an immunohistochemical study of paired liver biopsies before treatment and after clinical remission. Eur J Gastroenterol Hepatol 2010;22:264-9. [PMID: 20009940 DOI: 10.1097/MEG.0b013e328326cab6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
24 Quail MA, Russell RK, Bellamy C, Mieli-Vergani G, Gillett PM. Seronegative autoimmune hepatitis presenting after diagnosis of coeliac disease: a case report. Eur J Gastroenterol Hepatol. 2009;21:576-579. [PMID: 19318969 DOI: 10.1097/meg.0b013e3282fa1400] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
25 Saadah OI, Bokhary RY. Anti-mitochondrial antibody positive autoimmune hepatitis triggered by EBV infection in a young girl. Arab Journal of Gastroenterology 2013;14:130-2. [DOI: 10.1016/j.ajg.2013.05.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
26 Lapierre P, Lamarre A. Regulatory T Cells in Autoimmune and Viral Chronic Hepatitis. J Immunol Res. 2015;2015:479703. [PMID: 26106627 DOI: 10.1155/2015/479703] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
27 Czaja AJ, Bianchi FB, Carpenter HA, Krawitt EL, Lohse AW, Manns MP, McFarlane IG, Mieli-Vergani G, Toda G, Vergani D, Vierling J, Zeniya M. Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology. 2005;41:207-215. [PMID: 15690485 DOI: 10.1002/hep.20539] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 4.0] [Reference Citation Analysis]
28 Mieli-Vergani G, Vergani D. Autoimmune paediatric liver disease. World J Gastroenterol. 2008;14:3360-3367. [PMID: 18528933 DOI: 10.3748/wjg.14.3360] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
29 Obermayer-straub P, Manns MP. 6 Autoimmune polyglandular syndromes. Baillière's Clinical Gastroenterology 1998;12:293-315. [DOI: 10.1016/s0950-3528(98)90136-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
30 Alsayed MAL, Elbeah SM, El-Desoky MM, Elziny SM, Megahed A. Polymorphism in Macrophage Migration Inhibitory Factor -173GC in Pediatric Patients with Autoimmune Hepatitis. Pediatr Gastroenterol Hepatol Nutr 2020;23:63-71. [PMID: 31988876 DOI: 10.5223/pghn.2020.23.1.63] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Cuarterolo M, Ciocca M, Velasco CC, Ramonet M, González T, López S, Garsd A, Álvarez F. Follow-up of Children With Autoimmune Hepatitis Treated With Cyclosporine. Journal of Pediatric Gastroenterology & Nutrition 2006;43:635-9. [DOI: 10.1097/01.mpg.0000235975.75120.38] [Cited by in Crossref: 62] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
32 Cassinotti A, Birindelli S, Clerici M, Trabattoni D, Lazzaroni M, Ardizzone S, Colombo R, Rossi E, Porro GB. HLA and autoimmune digestive disease: a clinically oriented review for gastroenterologists. Am J Gastroenterol. 2009;104:195-217; quiz 194, 218. [PMID: 19098870 DOI: 10.1038/ajg.2008.10] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
33 Picceli V, Skare T, Nisihara R, Kotze L, Messias-reason I, Utiyama S. Spectrum of autoantibodies for gastrointestinal autoimmune diseases in systemic lupus erythematosus patients. Lupus 2013;22:1150-5. [DOI: 10.1177/0961203313503911] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
34 Özen H, Koçak N, Saltik IN, Yüce A, Gürakan F. Autoimmune hepatitis. Indian J Pediatr 2001;68:725-8. [DOI: 10.1007/bf02752411] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
35 You BC, Jeong SW, Jang JY, Goo SM, Kim SG, Kim YS, Jeon CH, Jeen YM. Liver Cirrhosis Due to Autoimmune Hepatitis Combined with Systemic Sclerosis. Korean J Gastroenterol 2012;59:48. [DOI: 10.4166/kjg.2012.59.1.48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
36 Miyakawa H, Kitazawa E, Kikuchi K, Fujikawa H, Kawaguchi N, Abe K, Matsushita M, Matsushima H, Igarashi T, Hankins RW. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C. Autoimmunity. 2000;33:23-32. [PMID: 11204250 DOI: 10.3109/08916930108994106] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
37 Czaja AJ. Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut Liver. 2016;10:177-203. [PMID: 26934884 DOI: 10.5009/gnl15352] [Cited by in Crossref: 70] [Cited by in F6Publishing: 48] [Article Influence: 14.0] [Reference Citation Analysis]
38 Aw MM, Dhawan A, Samyn M, Bargiota A, Mieli-Vergani G. Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up. J Hepatol. 2009;51:156-160. [PMID: 19446911 DOI: 10.1016/j.jhep.2009.02.024] [Cited by in Crossref: 82] [Cited by in F6Publishing: 65] [Article Influence: 6.8] [Reference Citation Analysis]
39 Bittencourt PL, Goldberg AC, Cançado EL, Porta G, Carrilho FJ, Farias AQ, Palacios SA, Chiarella JM, Abrantes-Lemos CP, Baggio VL. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am J Gastroenterol. 1999;94:1906-1913. [PMID: 10406258 DOI: 10.1111/j.1572-0241.1999.01229.x] [Cited by in Crossref: 118] [Cited by in F6Publishing: 99] [Article Influence: 5.4] [Reference Citation Analysis]
40 . EASL Clinical Practice Guidelines: Autoimmune hepatitis. Journal of Hepatology 2015;63:971-1004. [DOI: 10.1016/j.jhep.2015.06.030] [Cited by in Crossref: 489] [Cited by in F6Publishing: 342] [Article Influence: 81.5] [Reference Citation Analysis]
41 Vergani D, Mieli-vergani G. Autoimmune Hepatitis and Sclerosing Cholangitis. Autoimmunity 2009;37:329-32. [DOI: 10.1080/08916930410001705420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
42 Low AS, Tan M, Garcia A, Aw M, Quak SH. Childhood autoimmune hepatitis in a paediatric unit of a tertiary care hospital. Singapore Med J 2014;55:648-51. [PMID: 25630319 DOI: 10.11622/smedj.2014179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
43 Pereira TC, Saron ML, Carvalho WA, Vilela MM, Hoehr NF, Hessel G. Research on zinc blood levels and nutritional status in adolescents with autoimmune hepatitis. Arq Gastroenterol 2011;48:62-5. [PMID: 21537545 DOI: 10.1590/s0004-28032011000100013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
44 Liberal R, Grant CR, Holder BS, Ma Y, Mieli-Vergani G, Vergani D, Longhi MS. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway. Hepatology. 2012;56:677-686. [PMID: 22371007 DOI: 10.1002/hep.25682] [Cited by in Crossref: 88] [Cited by in F6Publishing: 74] [Article Influence: 9.8] [Reference Citation Analysis]
45 Longhi MS, Mitry RR, Samyn M, Scalori A, Hussain MJ, Quaglia A, Mieli-Vergani G, Ma Y, Vergani D. Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells. Hepatology. 2009;50:130-142. [PMID: 19437492 DOI: 10.1002/hep.22914] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
46 Medina J, García-buey L, Moreno-otero R. Immunopathogenetic and therapeutic aspects of autoimmune hepatitis: REVIEW: AUTOIMMUNE HEPATITIS. Alimentary Pharmacology & Therapeutics 2003;17:1-16. [DOI: 10.1046/j.1365-2036.2003.01389.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
47 Ma Y, Okamoto M, Thomas MG, Bogdanos DP, Lopes AR, Portmann B, Underhill J, Dürr R, Mieli-vergani G, Vergani D. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease: Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology 2002;35:658-64. [DOI: 10.1053/jhep.2002.32092] [Cited by in Crossref: 180] [Cited by in F6Publishing: 134] [Article Influence: 10.0] [Reference Citation Analysis]
48 Di Giorgio A, D'Adda A, Marseglia A, Sonzogni A, Licini L, Nicastro E, D'Antiga L. Biliary features in liver histology of children with autoimmune liver disease. Hepatol Int 2019;13:510-8. [PMID: 31069759 DOI: 10.1007/s12072-019-09948-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
49 Goldberg AC, Bittencourt PL, Oliveira LC, Ramasawmy R, Marin ML, Palacios SA, Kalil J, Porta G. Autoimmune hepatitis in Brazil: an overview. Scand J Immunol. 2007;66:208-216. [PMID: 17635798 DOI: 10.1111/j.1365-3083.2007.01967.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
50 Trivedi PJ, Hirschfield GM. Review article: overlap syndromes and autoimmune liver disease. Aliment Pharmacol Ther. 2012;36:517-533. [PMID: 22817525 DOI: 10.1111/j.1365-2036.2012.05223.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 51] [Article Influence: 9.4] [Reference Citation Analysis]
51 Roggenbuck D, Mytilinaiou MG, Lapin SV, Reinhold D, Conrad K. Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity. Auto Immun Highlights 2012;3:119-25. [PMID: 26000135 DOI: 10.1007/s13317-012-0041-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
52 Bittencourt PL, Palácios SA, Cançado EL, Porta G, Drigo S, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC. Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor alpha polymorphisms at position -308. J Hepatol. 2001;35:24-28. [PMID: 11495038 DOI: 10.1016/s0168-8278(01)00072-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
53 Muratori L, Cataleta M, Muratori P, Lenzi M, Bianchi FB. Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis. Gut. 1998;42:721-726. [PMID: 9659171 DOI: 10.1136/gut.42.5.721] [Cited by in Crossref: 86] [Cited by in F6Publishing: 73] [Article Influence: 3.7] [Reference Citation Analysis]
54 Yamada M, Shibata H, Masugi Y, Ishi T, Kameyama K, Ebinuma H, Hasegawa T. Histological Changes in Autoimmune Hepatitis with Graves' Disease: A Child Case Report. Intern Med. 2017;56:2139-2143. [PMID: 28781316 DOI: 10.2169/internalmedicine.8417-16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Liberal R, Longhi MS, Mieli-vergani G, Vergani D. Pathogenesis of autoimmune hepatitis. Best Practice & Research Clinical Gastroenterology 2011;25:653-64. [DOI: 10.1016/j.bpg.2011.09.009] [Cited by in Crossref: 86] [Cited by in F6Publishing: 67] [Article Influence: 8.6] [Reference Citation Analysis]
56 Yamashita J, Iwamura C, Sasaki T, Mitsumori K, Ohshima K, Hada K, Hara N, Takahashi M, Kaneshiro Y, Tanaka H, Kaneko K, Nakayama T. Apolipoprotein A-II suppressed concanavalin A-induced hepatitis via the inhibition of CD4 T cell function. J Immunol 2011;186:3410-20. [PMID: 21300819 DOI: 10.4049/jimmunol.1002924] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
57 Junge N, Tiedau M, Verboom M, Hallensleben M, Blasczyk R, Schlue J, Goldschmidt I, Pfister E, Baumann U. Human leucocyte antigens and pediatric autoimmune liver disease: diagnosis and prognosis. Eur J Pediatr 2016;175:527-37. [DOI: 10.1007/s00431-015-2662-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
58 Skare TL, Nisihara RM, Haider O, Azevedo PM, Utiyama SR. Liver autoantibodies in patients with scleroderma. Clin Rheumatol 2011;30:129-32. [PMID: 20931345 DOI: 10.1007/s10067-010-1586-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
59 Chang M, Hadzic D, Rouassant SH, Jonas M, Kohn IJ, Negro F, Roberts E, Sibal A. Acute and Chronic Hepatitis: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition: . Journal of Pediatric Gastroenterology and Nutrition 2004;39:S584-8. [DOI: 10.1097/00005176-200406002-00002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
60 Smolka V, Tkachyk O, Ehrmann J, Karaskova E, Zapalka M, Volejnikova J. Acute onset of autoimmune hepatitis in children and adolescents. Hepatobiliary Pancreat Dis Int 2020;19:17-21. [PMID: 31474443 DOI: 10.1016/j.hbpd.2019.08.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Gabler WL. National Toxicology program report on fluoride and cancer. J Oreg Dent Assoc. 1991;60:32-33. [PMID: 1856781 DOI: 10.1016/s0140-6736(97)06478-7] [Cited by in Crossref: 320] [Cited by in F6Publishing: 39] [Article Influence: 10.7] [Reference Citation Analysis]
62 Narkewicz MR, Dell Olio D, Karpen SJ, Murray KF, Schwarz K, Yazigi N, Zhang S, Belle SH, Squires RH; Pediatric Acute Liver Failure Study Group. Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J Pediatr 2009;155:801-806.e1. [PMID: 19643443 DOI: 10.1016/j.jpeds.2009.06.005] [Cited by in Crossref: 92] [Cited by in F6Publishing: 54] [Article Influence: 7.7] [Reference Citation Analysis]
63 Mieli-Vergani G, Vergani D. Paediatric autoimmune liver disease. Arch Dis Child. 2013;98:1012-1017. [PMID: 24001955 DOI: 10.1136/archdischild-2013-303848] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
64 Ma Y, Su H, Yuksel M, Longhi MS, McPhail MJ, Wang P, Bansal S, Wong GW, Graham J, Yang L, J Thompson R, Doherty DG, Hadzic N, Zen Y, Quaglia A, Heneghan MA, Samyn M, Vergani D, Mieli-Vergani G. Human Leukocyte Antigen Profile Predicts Severity of Autoimmune Liver Disease in Children of European Ancestry. Hepatology 2021. [PMID: 33971035 DOI: 10.1002/hep.31893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
65 Maggiore G, Socie G, Sciveres M, Roque-afonso A, Nastasio S, Johanet C, Gottrand F, Fournier-favre S, Jacquemin E, Bernard O. Seronegative autoimmune hepatitis in children: Spectrum of disorders. Digestive and Liver Disease 2016;48:785-91. [DOI: 10.1016/j.dld.2016.03.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
66 Oettinger R, Brunnberg A, Gerner P, Wintermeyer P, Jenke A, Wirth S. Clinical features and biochemical data of Caucasian children at diagnosis of autoimmune hepatitis. Journal of Autoimmunity 2005;24:79-84. [DOI: 10.1016/j.jaut.2004.11.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
67 Vogel A, Manns MP, Strassburg CP. Autoimmunity and viruses. Clin Liver Dis. 2002;6:739-753. [PMID: 12362578 DOI: 10.1016/s1089-3261(02)00024-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
68 Bogdanos DP, Invernizzi P, Mackay IR, Vergani D. Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol 2008;14:3374-87. [PMID: 18528935 DOI: 10.3748/wjg.14.3374] [Cited by in CrossRef: 138] [Cited by in F6Publishing: 105] [Article Influence: 10.6] [Reference Citation Analysis]
69 Bae SH, Kim JS, Kim DH. Deflazacort for type-1 autoimmune hepatitis in a Korean girl. J Korean Med Sci. 2006;21:758-760. [PMID: 16891827 DOI: 10.3346/jkms.2006.21.4.758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
70 Sahebjam F, Vierling JM. Autoimmune hepatitis. Front Med 2015;9:187-219. [DOI: 10.1007/s11684-015-0386-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
71 Grønbaek L, Vilstrup H, Pedersen L, Jepsen P. Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: A Danish nationwide cohort study. Liver Int 2019;39:205-14. [PMID: 30218621 DOI: 10.1111/liv.13963] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
72 Della Corte C, Mosca A, Vania A, Alterio A, Alisi A, Nobili V. Pediatric liver diseases: current challenges and future perspectives. Expert Rev Gastroenterol Hepatol 2016;10:255-65. [PMID: 26641319 DOI: 10.1586/17474124.2016.1129274] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
73 Czaja AJ. Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis. Dig Dis Sci. 2017;62:2277-2292. [PMID: 28710658 DOI: 10.1007/s10620-017-4675-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
74 Jarasvaraparn C, Imran H, Siddiqui A, Wilson F, Gremse DA. Association of autoimmune hepatitis type 1 in a child with Evans syndrome. World J Hepatol 2017;9:1008-12. [PMID: 28878866 DOI: 10.4254/wjh.v9.i23.1008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
75 Fujisawa T, Sogo T, Komatsu H, Inui A. Autoimmune hepatitis in childhood. Hepatol Res 2007;37 Suppl 3:S496-500. [PMID: 17931209 DOI: 10.1111/j.1872-034X.2007.00248.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
76 Longhi MS, Hussain MJ, Bogdanos DP, Quaglia A, Mieli-Vergani G, Ma Y, Vergani D. Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology. 2007;46:472-484. [PMID: 17559153 DOI: 10.1002/hep.21658] [Cited by in Crossref: 91] [Cited by in F6Publishing: 78] [Article Influence: 6.5] [Reference Citation Analysis]
77 Frenzel C, Herkel J, Lüth S, Galle PR, Schramm C, Lohse AW. Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis. Am J Gastroenterol 2006;101:2731-6. [PMID: 17227520 DOI: 10.1111/j.1572-0241.2006.00830.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
78 Lowe D, John S. Autoimmune hepatitis: Appraisal of current treatment guidelines. World J Hepatol. 2018;10:911-923. [PMID: 30631396 DOI: 10.4254/wjh.v10.i12.911] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
79 Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology. 2010;139:58-72.e4. [PMID: 20451521 DOI: 10.1053/j.gastro.2010.04.053] [Cited by in Crossref: 184] [Cited by in F6Publishing: 151] [Article Influence: 16.7] [Reference Citation Analysis]
80 Abu Faddan NH, Abdel-baky L, Aly SA, Rashed HG. Clinico-laboratory study on children with auto-immune hepatitis in Upper Egypt. Arab Journal of Gastroenterology 2011;12:178-83. [DOI: 10.1016/j.ajg.2011.11.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
81 Rahim MN, Miquel R, Heneghan MA. Approach to the patient with acute severe autoimmune hepatitis. JHEP Rep 2020;2:100149. [PMID: 32995712 DOI: 10.1016/j.jhepr.2020.100149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
82 Aizawa Y, Hokari A. Autoimmune hepatitis: current challenges and future prospects. Clin Exp Gastroenterol. 2017;10:9-18. [PMID: 28176894 DOI: 10.2147/ceg.s101440] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 6.3] [Reference Citation Analysis]
83 Czaja AJ, Manns MP, McFarlane IG, Hoofnagle JH. Autoimmune hepatitis: the investigational and clinical challenges. Hepatology. 2000;31:1194-1200. [PMID: 10796898 DOI: 10.1053/he.2000.5980] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 2.2] [Reference Citation Analysis]
84 Yeh SH, Ni YH, Jeng YM, Chen HL, Wu JF, Chang MH. Emerging importance of autoimmune hepatitis in children in Taiwan, an endemic area for viral hepatitis. Pediatr Neonatol 2009;50:65-9. [PMID: 19453081 DOI: 10.1016/S1875-9572(09)60035-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
85 Liberal R, Grant CR, Mieli-vergani G, Vergani D. Autoimmune hepatitis: A comprehensive review. Journal of Autoimmunity 2013;41:126-39. [DOI: 10.1016/j.jaut.2012.11.002] [Cited by in Crossref: 125] [Cited by in F6Publishing: 101] [Article Influence: 15.6] [Reference Citation Analysis]
86 Czaja AJ. The overlap syndromes of autoimmune hepatitis. Dig Dis Sci. 2013;58:326-343. [PMID: 22918690 DOI: 10.1007/s10620-012-2367-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 0.3] [Reference Citation Analysis]
87 Roepe IG, Vierling JM, Goss JA, Miloh T. Presentation and Outcomes of Autoimmune Hepatitis Type 1 and Type 2 in Children: A Single-center Study. J Pediatr Gastroenterol Nutr 2021;72:101-7. [PMID: 32796427 DOI: 10.1097/MPG.0000000000002892] [Reference Citation Analysis]
88 Saadah OI, Smith AL, Hardikar W. Long-term outcome of autoimmune hepatitis in children. J Gastroenterol Hepatol. 2001;16:1297-1302. [PMID: 11903750 DOI: 10.1046/j.1440-1746.2001.02615.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
89 Casswall TH, Németh A, Nilsson I, Wadström T, Nilsson HO. Helicobacter species DNA in liver and gastric tissues in children and adolescents with chronic liver disease. Scand J Gastroenterol. 2010;45:160-167. [PMID: 20095882 DOI: 10.3109/00365520903426915] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
90 Bahar RJ, Yanni GS, Martin MG, Mcdiarmid SV, Vargas JH, Gershman GB, Heyman MB, Rosenthal P, Tipton JR, Nanjundiah P, Starr A, Ament ME. ORTHOTOPIC LIVER TRANSPLANTATION FOR AUTOIMMUNE HEPATITIS AND CRYPTOGENIC CHRONIC HEPATITIS IN CHILDREN1: . Transplantation 2001;72:829-33. [DOI: 10.1097/00007890-200109150-00015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
91 Czaja AJ. Autoantibodies as prognostic markers in autoimmune liver disease. Dig Dis Sci. 2010;55:2144-2161. [PMID: 20464491 DOI: 10.1007/s10620-010-1268-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
92 Liberal R, Vergani D, Mieli-vergani G. Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation. Liver Transpl 2016;22:1275-83. [DOI: 10.1002/lt.24490] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
93 Kelly D, Sibal A. Current status of liver transplantation. Indian J Pediatr 2003;70:731-6. [PMID: 14620189 DOI: 10.1007/BF02724316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
94 Vergani D, Mackay IR, Mieli-vergani G. Hepatitis. The Autoimmune Diseases. Elsevier; 2014. pp. 889-907. [DOI: 10.1016/b978-0-12-384929-8.00061-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
95 Pathak S, Kamat D. Autoimmune Hepatitis in Children. Pediatr Ann 2018;47:e81-6. [PMID: 29446799 DOI: 10.3928/19382359-20180126-01] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
96 Loddo I, Romano C, Cutrupi MC, Sciveres M, Riva S, Salpietro A, Ferraù V, Gallizzi R, Briuglia S. Autoimmune liver disease in Noonan Syndrome. European Journal of Medical Genetics 2015;58:188-90. [DOI: 10.1016/j.ejmg.2014.12.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
97 Sun W, Wu HY, Chen S. Influence of TBX21 T-1993C variant on autoimmune hepatitis development by Yin-Yang 1 binding. World J Gastroenterol 2017;23:8500-11. [PMID: 29358858 DOI: 10.3748/wjg.v23.i48.8500] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
98 Ferri PM, Simões e Silva AC, Torres KC, Silva SL, Aquino DJ, Ferreira ML, Fagundes ED, Miranda DM, Ferreira AR. Autoimmune Hepatitis and Autoimmune Hepatitis Overlap With Sclerosing Cholangitis: Immunophenotype Markers in Children and Adolescents. Journal of Pediatric Gastroenterology & Nutrition 2018;66:204-11. [DOI: 10.1097/mpg.0000000000001783] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
99 Kawashima H, Kato N, Ioi H, Nishimata S, Watanabe C, Kashiwagi Y, Takekuma K, Hoshika A, Szenborn L, Bergman K. mRNA expression of T-helper 1, T-helper 2 cytokines in autoimmune hepatitis in childhood. Pediatr Int 2008;50:284-6. [DOI: 10.1111/j.1442-200x.2008.02584.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
100 Gregorio GV, Portmann B, Mowat AP, Vergani D, Mieli-Vergani G. A 12-year-old girl with antimitochondrial antibody-positive autoimmune hepatitis. J Hepatol. 1997;27:751-754. [PMID: 9365052 DOI: 10.1016/s0168-8278(97)80093-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
101 Zellos A, Boitnott JK, Schwarz KB. New-onset autoimmune hepatitis in young patients with preexisting liver disease. Dig Liver Dis 2010;42:657-60. [PMID: 20227931 DOI: 10.1016/j.dld.2010.01.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
102 Muratori P, Lenzi M, Cassani F, Lalanne C, Muratori L. Diagnostic approach to autoimmune hepatitis. Expert Rev Clin Immunol 2017;13:769-79. [PMID: 28480763 DOI: 10.1080/1744666X.2017.1327355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
103 Mieli-vergani G, Vergani D. Sclerosing cholangitis in the paediatric patient. Best Practice & Research Clinical Gastroenterology 2001;15:681-90. [DOI: 10.1053/bega.2001.0213] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
104 Squires RH. Autoimmune hepatitis in children. Curr Gastroenterol Rep. 2004;6:225-230. [PMID: 15128490 DOI: 10.1007/s11894-004-0012-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
105 Vergani D, Mieli-Vergani G. Autoimmune hepatitis. Autoimmun Rev. 2003;2:241-247. [PMID: 12965174 DOI: 10.1016/s1568-9972(03)00017-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
106 Di Giorgio A, Bravi M, Bonanomi E, Alessio G, Sonzogni A, Zen Y, Colledan M, D’antiga L. Fulminant Hepatic Failure of Autoimmune Aetiology in Children. Journal of Pediatric Gastroenterology & Nutrition 2015;60:159-64. [DOI: 10.1097/mpg.0000000000000593] [Cited by in Crossref: 27] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
107 Muratori L, Longhi MS. The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies. J Autoimmun. 2013;46:74-80. [PMID: 23871639 DOI: 10.1016/j.jaut.2013.06.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
108 Kogan J, Safadi R, Ashur Y, Shouval D, Ilan Y. Prognosis of symptomatic vs asymptomatic autoimmune hepatitis: a study of 68 patients. J Clin Gastroenterol. 2002;35:75-81. [PMID: 12080231 DOI: 10.1097/00004836-200207000-00016] [Cited by in Crossref: 83] [Cited by in F6Publishing: 72] [Article Influence: 4.4] [Reference Citation Analysis]
109 Boberg KM. Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis. 2002;6:635-647. [PMID: 12362572 DOI: 10.1016/s1089-3261(02)00021-1] [Cited by in Crossref: 70] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
110 Zhang WC, Zhao FR, Chen J, Chen WX. Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis. PLoS One. 2014;9:e92267. [PMID: 24651126 DOI: 10.1371/journal.pone.0092267] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
111 El-Din Elshazly LB, Youssef AM, Mahmoud NH, Ibrahim MM. Study of nonstandard auto-antibodies as prognostic markers in auto immune hepatitis in children. Ital J Pediatr 2009;35:22. [PMID: 19712439 DOI: 10.1186/1824-7288-35-22] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
112 Dyson JK, De Martin E, Dalekos GN, Drenth JP, Herkel J, Hubscher SG, Kelly D, Lenzi M, Milkiewicz P, Oo YH, Heneghan MA, Lohse AW; the IAIHG Consortium. Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop. Aliment Pharmacol Ther 2019;49:528-36. [DOI: 10.1111/apt.15111] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
113 Lapierre P, Béland K, Martin C, Alvarez F, Alvarez F. Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis. Hepatology. 2010;51:1789-1798. [PMID: 20232291 DOI: 10.1002/hep.23536] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
114 Vierling JM. Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management. Clin Gastroenterol Hepatol. 2015;13:2088-2108. [PMID: 26284592 DOI: 10.1016/j.cgh.2015.08.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 6.2] [Reference Citation Analysis]
115 Seerat I, Khan EUD, Atique M, Aujla UI. Clinical spectrum of chronic liver disease with final outcome in children at a tertiary centre: A single - centre study. Pak J Med Sci 2021;37:680-3. [PMID: 34104147 DOI: 10.12669/pjms.37.3.3862] [Reference Citation Analysis]
116 Ben-Ari Z, Czaja AJ. Autoimmune hepatitis and its variant syndromes. Gut 2001;49:589-94. [PMID: 11559660 DOI: 10.1136/gut.49.4.589] [Cited by in Crossref: 69] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
117 Yachha SK, Srivastava A, Chetri K, Saraswat VA, Krishnani N. Autoimmune liver disease in children. J Gastroenterol Hepatol. 2001;16:674-677. [PMID: 11422621 DOI: 10.1046/j.1440-1746.2001.02492.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
118 Huang J, Yuan Q, Zhu H, Yin L, Hong S, Dong Z, Jin W, Dong C. IL-17C/IL-17RE Augments T Cell Function in Autoimmune Hepatitis. J Immunol 2017;198:669-80. [PMID: 27956525 DOI: 10.4049/jimmunol.1600977] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
119 Longhi MS, Hussain MJ, Mitry RR, Arora SK, Mieli-Vergani G, Vergani D, Ma Y. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol. 2006;176:4484-4491. [PMID: 16547287 DOI: 10.4049/jimmunol.176.7.4484] [Cited by in Crossref: 233] [Cited by in F6Publishing: 204] [Article Influence: 15.5] [Reference Citation Analysis]
120 Radzimski C, Probst C, Teegen B, Rentzsch K, Blöcker IM, Dähnrich C, Schlumberger W, Stöcker W, Bogdanos DP, Komorowski L. Development of a recombinant cell-based indirect immunofluorescence assay for the determination of autoantibodies against soluble liver antigen in autoimmune hepatitis. Clin Dev Immunol 2013;2013:572815. [PMID: 23401700 DOI: 10.1155/2013/572815] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
121 Alvarez F. Treatment of autoimmune hepatitis: Current and future therapies. Curr Treat Options Gastro 2004;7:413-20. [DOI: 10.1007/s11938-004-0054-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
122 Kirstein MM, Metzler F, Geiger E, Heinrich E, Hallensleben M, Manns MP, Vogel A. Prediction of short- and long-term outcome in patients with autoimmune hepatitis. Hepatology. 2015;62:1524-1535. [PMID: 26178791 DOI: 10.1002/hep.27983] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 12.5] [Reference Citation Analysis]
123 Czaja AJ, Freese DK; American Association for the Study of Liver Disease. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479-497. [PMID: 12143059 DOI: 10.1053/jhep.2002.34944] [Cited by in Crossref: 404] [Cited by in F6Publishing: 332] [Article Influence: 21.3] [Reference Citation Analysis]
124 Czaja AJ, Homburger HA. Autoantibodies in liver disease. Gastroenterology. 2001;120:239-249. [PMID: 11208733 DOI: 10.1053/gast.2001.20223] [Cited by in Crossref: 93] [Cited by in F6Publishing: 77] [Article Influence: 4.7] [Reference Citation Analysis]
125 Xiang D, Xia Q, Chen D, Feng X, Zhao Y, Liu Y, Liao H, Liu Y, Li N, Yan H. Detection of D-3-phosphoglycerate dehydrogenase autoantibodies in patients with autoimmune hepatitis: Clinical significance evaluation. Hepatol Res 2011;41:867-76. [PMID: 21707887 DOI: 10.1111/j.1872-034X.2011.00839.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
126 Wong G, Yeong T, Lawrence D, Yeoman AD, Verma S, Heneghan MA. Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long-term outcomes. Liver Int 2017;37:449-57. [DOI: 10.1111/liv.13236] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
127 Liberal R, Mieli-vergani G, Vergani D. Clinical significance of autoantibodies in autoimmune hepatitis. Journal of Autoimmunity 2013;46:17-24. [DOI: 10.1016/j.jaut.2013.08.001] [Cited by in Crossref: 58] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
128 Kriese S, Heneghan MA. Autoimmune hepatitis. Medicine 2011;39:580-4. [DOI: 10.1016/j.mpmed.2011.07.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
129 Czaja AJ. Autoimmune hepatitis. Part B: diagnosis. Expert Rev Gastroenterol Hepatol. 2007;1:129-143. [PMID: 19072441 DOI: 10.1586/17474124.1.1.129] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
130 Czaja AJ. Diagnosis and management of autoimmune hepatitis. Clin Liver Dis 2015;19:57-79. [PMID: 25454297 DOI: 10.1016/j.cld.2014.09.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
131 Ngu JH, Gearry RB, Frampton CM, Stedman CA. Predictors of poor outcome in patients w ith autoimmune hepatitis: A population-based study. Hepatology. 2013;57:2399-2406. [PMID: 23359353 DOI: 10.1002/hep.26290] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 8.4] [Reference Citation Analysis]
132 Longhi MS, Liberal R, Holder B, Robson SC, Ma Y, Mieli–vergani G, Vergani D. Inhibition of Interleukin-17 Promotes Differentiation of CD25 Cells Into Stable T Regulatory Cells in Patients With Autoimmune Hepatitis. Gastroenterology 2012;142:1526-1535.e6. [DOI: 10.1053/j.gastro.2012.02.041] [Cited by in Crossref: 79] [Cited by in F6Publishing: 64] [Article Influence: 8.8] [Reference Citation Analysis]
133 Nalepa A, Woźniak M, Cielecka-Kuszyk J, Stefanowicz M, Jankowska I, Dądalski M, Pawłowska J. Acute-on-chronic hepatitis. A case report of autoimmune hepatitis/primary sclerosing cholangitis/ulcerative colitis overlap syndrome in a 15-year-old patient. Clin Exp Hepatol. 2017;3:28-32. [PMID: 28856287 DOI: 10.5114/ceh.2017.65501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
134 Strassburg CP, Manns MP. Autoimmune hepatitis in the elderly: What is the difference? Journal of Hepatology 2006;45:480-2. [DOI: 10.1016/j.jhep.2006.07.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
135 Nguyen Canh H, Harada K, Ouchi H, Sato Y, Tsuneyama K, Kage M, Nakano M, Yoshizawa K, Takahashi A, Abe M, Kang JH, Koike K, Inui A, Fujisawa T, Takaki A, Arinaga-Hino T, Torimura T, Suzuki Y, Fujiwara K, Zeniya M, Ohira H, Tanaka A, Takikawa H; Intractable Liver and Biliary Diseases Study Group of Japan. Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients. J Clin Pathol 2017;70:961-9. [PMID: 28428284 DOI: 10.1136/jclinpath-2016-204271] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 8.8] [Reference Citation Analysis]
136 Liberal R, de Boer YS, Heneghan MA. Established and novel therapeutic options for autoimmune hepatitis. The Lancet Gastroenterology & Hepatology 2021;6:315-26. [DOI: 10.1016/s2468-1253(20)30328-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Venick RS, McDiarmid SV, Farmer DG, Gornbein J, Martin MG, Vargas JH, Ament ME, Busuttil RW. Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis. Am J Transplant. 2007;7:955-963. [PMID: 17391135 DOI: 10.1111/j.1600-6143.2006.01717.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 54] [Article Influence: 5.6] [Reference Citation Analysis]
138 Lapierre P, Béland K, Alvarez F. Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis. Transl Res. 2007;149:107-113. [PMID: 17320796 DOI: 10.1016/j.trsl.2006.11.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
139 Liwinski T, Schramm C. Autoimmune hepatitis — update on clinical management in 2017. Clinics and Research in Hepatology and Gastroenterology 2017;41:617-25. [DOI: 10.1016/j.clinre.2017.07.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
140 Kanzler S, Weidemann C, Gerken G, Löhr HF, Galle PR, Meyer zum Büschenfelde KH, Lohse AW. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J Hepatol 1999;31:635-40. [PMID: 10551386 DOI: 10.1016/s0168-8278(99)80342-0] [Cited by in Crossref: 93] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
141 Muratori L, Parola M, Ripalti A, Robino G, Muratori P, Bellomo G, Carini R, Lenzi M, Landini MP, Albano E, Bianchi FB. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut 2000;46:553-61. [PMID: 10716687 DOI: 10.1136/gut.46.4.553] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 3.8] [Reference Citation Analysis]
142 Francque S, Vonghia L, Ramon A, Michielsen P. Epidemiology and treatment of autoimmune hepatitis. Hepat Med. 2012;4:1-10. [PMID: 24367228 DOI: 10.2147/hmer.s16321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
143 Panetta F, Nobili V, Sartorelli MR, Papa RE, Ferretti F, Alterio A, Diamanti A. Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management. Paediatr Drugs. 2012;14:35-41. [PMID: 22149550 DOI: 10.2165/11593150-000000000-00000] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
144 Sakaki M, Hiroishi K, Baba T, Ito T, Hirayama Y, Saito K, Tonoike T, Kushima M, Imawari M. Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis. Hepatol Res 2008;38:354-61. [PMID: 18021223 DOI: 10.1111/j.1872-034X.2007.00284.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
145 Grant CR, Liberal R, Holder BS, Cardone J, Ma Y, Robson SC, Mieli-Vergani G, Vergani D, Longhi MS. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T helper type 17 cells in autoimmune hepatitis. Hepatology. 2013; Jun 20. [Epub ahead of print]. [PMID: 23787765 DOI: 10.1002/hep.26583] [Cited by in Crossref: 112] [Cited by in F6Publishing: 102] [Article Influence: 16.0] [Reference Citation Analysis]
146 Nastasio S, Sciveres M, Matarazzo L, Malaventura C, Cirillo F, Riva S, Maggiore G. Long-term follow-up of children and young adults with autoimmune hepatitis treated with cyclosporine. Digestive and Liver Disease 2019;51:712-8. [DOI: 10.1016/j.dld.2018.10.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
147 Alvarez F, Berg P, Bianchi F, Bianchi L, Burroughs A, Cancado E, Chapman R, Cooksley W, Czaja A, Desmet V, Donaldson P, Eddleston A, Fainboim L, Heathcote J, Homberg J, Hoofnagle J, Kakumu S, Krawitt E, Mackay I, Macsween R, Maddrey W, Manns M, Mcfarlane I, Meyer zum Büschenfelde K, Mieli-vergani G, Nakanuma Y, Nishioka M, Penner E, Porta G, Portmann B, Reed W, Rodes J, Schalm S, Scheuer P, Schrumpf E, Seki T, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. Journal of Hepatology 1999;31:929-38. [DOI: 10.1016/s0168-8278(99)80297-9] [Cited by in Crossref: 1855] [Cited by in F6Publishing: 458] [Article Influence: 84.3] [Reference Citation Analysis]
148 Bailloud R, Bertin D, Roquelaure B, Roman C, Ballot E, Johanet C, Desplat-jégo S. Anti-mitochondrial-2 antibodies (anti-PDC-E2): A marker for autoimmune hepatitis of children? Clinics and Research in Hepatology and Gastroenterology 2012;36:e57-9. [DOI: 10.1016/j.clinre.2012.06.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
149 Rojas CP, Bodicharla R, Campuzano-Zuluaga G, Hernandez L, Rodriguez MM. Autoimmune hepatitis and primary sclerosing cholangitis in children and adolescents. Fetal Pediatr Pathol. 2014;33:202-209. [PMID: 24754367 DOI: 10.3109/15513815.2014.898721] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
150 Chai PF, Lee WS, Brown RM, Mcpartland JL, Foster K, Mckiernan PJ, Kelly DA. Childhood Autoimmune Liver Disease: Indications and Outcome of Liver Transplantation. Journal of Pediatric Gastroenterology & Nutrition 2010;50:295-302. [DOI: 10.1097/mpg.0b013e3181bf0ef7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
151 de Oliveira LC, Goldberg AC, Marin ML, Schneidwind KR, Frade AF, Kalil J, Miura IK, Pugliese RP, Danesi VL, Porta G. Autoimmune Hepatitis in Brazilian Children: IgE and Genetic Polymorphisms in Associated Genes. J Immunol Res 2015;2015:679813. [PMID: 26693492 DOI: 10.1155/2015/679813] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
152 Engel B, Laschtowitz A, Janik MK, Junge N, Baumann U, Milkiewicz P, Taubert R, Sebode M. Genetic aspects of adult and pediatric autoimmune hepatitis: A concise review. Eur J Med Genet 2021;64:104214. [PMID: 33812046 DOI: 10.1016/j.ejmg.2021.104214] [Reference Citation Analysis]
153 Terziroli Beretta-piccoli B, Mieli-vergani G, Vergani D. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview. Journal of Autoimmunity 2018;95:144-58. [DOI: 10.1016/j.jaut.2018.10.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
154 Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children. Clin Liver Dis 2002;6:623-34. [PMID: 12362571 DOI: 10.1016/s1089-3261(02)00020-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
155 Oikonomou KG, Zachou K, Dalekos GN. Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity. Autoimmun Rev. 2011;10:389-396. [PMID: 21241830 DOI: 10.1016/j.autrev.2010.12.009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 5.8] [Reference Citation Analysis]
156 Ferrari R, Pappas G, Agostinelli D, Muratori P, Muratori L, Lenzi M, Verucchi G, Cassani F, Chiodo F, Bianchi FB. Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the ‘acute’ type. QJM. 2004;97:407-412. [PMID: 15208428 DOI: 10.1093/qjmed/hch072] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 3.2] [Reference Citation Analysis]
157 Sciveres M, Caprai S, Palla G, Ughi C, Maggiore G. Effectiveness and safety of ciclosporin as therapy for autoimmune diseases of the liver in children and adolescents. Aliment Pharmacol Ther. 2004;19:209-217. [PMID: 14723612 DOI: 10.1046/j.1365-2036.2003.01754.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
158 Bossen L, Gerussi A, Lygoura V, Mells GF, Carbone M, Invernizzi P. Support of precision medicine through risk-stratification in autoimmune liver diseases – histology, scoring systems, and non-invasive markers. Autoimmunity Reviews 2018;17:854-65. [DOI: 10.1016/j.autrev.2018.02.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
159 Hovinga IC, Stam ED, Mearin ML, Mul D. A girl with type 1 diabetes and a yellowish appearance. BMJ Case Rep 2010;2010:bcr0420102899. [PMID: 22797478 DOI: 10.1136/bcr.04.2010.2899] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
160 Sogo T, Takahashi A, Inui A, Fujisawa T, Ohira H, Takikawa H; Japan AIH Study Group (JAIHSG). Clinical features of pediatric autoimmune hepatitis in Japan: A nationwide survey: Pediatric autoimmune hepatitis in Japan. Hepatol Res 2018;48:286-94. [DOI: 10.1111/hepr.12998] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
161 Czaja AJ. Current concepts in autoimmune hepatitis. Annals of Hepatology 2005;4:6-24. [DOI: 10.1016/s1665-2681(19)32081-2] [Cited by in Crossref: 48] [Article Influence: 3.0] [Reference Citation Analysis]
162 Sebode M, Weiler-Normann C, Liwinski T, Schramm C. Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance. Front Immunol. 2018;9:609. [PMID: 29636752 DOI: 10.3389/fimmu.2018.00609] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 11.7] [Reference Citation Analysis]
163 Sonthalia N, Rathi PM, Jain SS, Surude RG, Mohite AR, Pawar SV, Contractor Q. Natural History and Treatment Outcomes of Severe Autoimmune Hepatitis. J Clin Gastroenterol. 2017;51:548-556. [PMID: 28272079 DOI: 10.1097/mcg.0000000000000805] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
164 McFarlane IG. Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features. Clin Liver Dis 2002;6:605-21. [PMID: 12362570 DOI: 10.1016/s1089-3261(02)00019-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
165 Baldassano RN, Piccoli DA. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am. 1999;28:445-458. [PMID: 10372276 DOI: 10.1016/s0889-8553(05)70064-9] [Cited by in Crossref: 137] [Cited by in F6Publishing: 43] [Article Influence: 6.2] [Reference Citation Analysis]
166 Béland K, Lapierre P, Alvarez F. Influence of genes, sex, age and environment on the onset of autoimmune hepatitis. World J Gastroenterol. 2009;15:1025-1034. [PMID: 19266593 DOI: 10.3748/wjg.15.1025] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
167 Jossen J, Annunziato R, Kim HS, Chu J, Arnon R. Liver Transplantation for Children With Primary Sclerosing Cholangitis and Autoimmune Hepatitis: UNOS Database Analysis. J Pediatr Gastroenterol Nutr. 2017;64:e83-e87. [PMID: 27755342 DOI: 10.1097/mpg.0000000000001438] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 4.3] [Reference Citation Analysis]
168 Vergani D, Mieli-vergani G. Autoimmune hepatitis: . Current Opinion in Gastroenterology 2001;17:562-7. [DOI: 10.1097/00001574-200111000-00014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
169 Maggiore G, Nastasio S, Sciveres M. Juvenile autoimmune hepatitis: Spectrum of the disease. World J Hepatol. 2014;6:464-476. [PMID: 25067998 DOI: 10.4254/wjh.v6.i7.464] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
170 Pelli N, Fensom AH, Slade C, Boa F, Mieli-Vergani G, Vergani D. Argininosuccinate lyase: a new autoantigen in liver disease. Clin Exp Immunol. 1998;114:455-461. [PMID: 9844057 DOI: 10.1046/j.1365-2249.1998.00754.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
171 Liberal R, Zen Y, Mieli-Vergani G, Vergani D. Liver transplantation and autoimmune liver diseases. Liver Transpl. 2013;19:1065-1077. [PMID: 23873751 DOI: 10.1002/lt.23704] [Cited by in Crossref: 57] [Cited by in F6Publishing: 31] [Article Influence: 7.1] [Reference Citation Analysis]
172 Yeoman AD, Westbrook RH, Al-Chalabi T, Carey I, Heaton ND, Portmann BC, Heneghan MA. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology. 2009;50:538-545. [PMID: 19575457 DOI: 10.1002/hep.23042] [Cited by in Crossref: 105] [Cited by in F6Publishing: 78] [Article Influence: 8.8] [Reference Citation Analysis]
173 Czaja AJ. Autoimmune hepatitis in special patient populations. Best Pract Res Clin Gastroenterol. 2011;25:689-700. [PMID: 22117635 DOI: 10.1016/j.bpg.2011.09.011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
174 Lee WS, Lum SH, Lim CB, Chong SY, Khoh KM, Ng RT, Teo KM, Boey CC, Pailoor J. Characteristics and outcome of autoimmune liver disease in Asian children. Hepatol Int. 2015;9:292-302. [PMID: 25788179 DOI: 10.1007/s12072-014-9558-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
175 Vergani D, Longhi MS, Bogdanos DP, Ma Y, Mieli-Vergani G. Autoimmune hepatitis. Semin Immunopathol. 2009;31:421-435. [PMID: 19533129 DOI: 10.1007/s00281-009-0170-7] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 5.8] [Reference Citation Analysis]
176 Radhakrishnan KR, Alkhouri N, Worley S, Arrigain S, Hupertz V, Kay M, Yerian L, Wyllie R, Feldstein AE. Autoimmune hepatitis in children—Impact of cirrhosis at presentation on natural history and long-term outcome. Digestive and Liver Disease 2010;42:724-8. [DOI: 10.1016/j.dld.2010.01.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
177 Muratori P, Czaja AJ, Muratori L, Granito A, Guidi M, Ferri S, Volta U, Mantovani W, Pappas G, Cassani F. Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C. Dig Dis Sci. 2007;52:179-184. [PMID: 17160474 DOI: 10.1007/s10620-006-9495-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
178 Sucher E, Sucher R, Gradistanac T, Brandacher G, Schneeberger S, Berg T. Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies. J Immunol Res 2019;2019:9437043. [PMID: 31886312 DOI: 10.1155/2019/9437043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
179 Miyakawa H, Kikazawa E, Abe K, Kikuchi K, Fujikawa H, Matsushita M, Kawaguchi N, Morizane T, Ohya K, Kako M. Detection of Anti-LKM-1(Anti-CYP2D6) by an: Enzyme-Linked Immunosorbent Assay in Adult Patients with Chronic Liver Diseases. Autoimmunity 2009;30:107-14. [DOI: 10.3109/08916939908994768] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
180 Bogdanos DP, Choudhuri K, Vergani D. Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver. 2001;21:225-232. [PMID: 11454184 DOI: 10.1034/j.1600-0676.2001.021004225.x] [Cited by in Crossref: 124] [Cited by in F6Publishing: 107] [Article Influence: 6.2] [Reference Citation Analysis]
181 Alvarez F. Autoimmune Hepatitis and Primary Sclerosing Cholangitis. Clinics in Liver Disease 2006;10:89-107. [DOI: 10.1016/j.cld.2005.10.009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
182 Bridoux-Henno L, Maggiore G, Johanet C, Fabre M, Vajro P, Dommergues JP, Reinert P, Bernard O. Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody. Clin Gastroenterol Hepatol. 2004;2:825-830. [PMID: 15354284 DOI: 10.1016/s1542-3565(04)00354-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
183 Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, Okamoto R, Takaguchi K, Ikeda H, Makino Y, Sakaguchi K, Ando M, Yamamoto K. Clinical features of type 1 autoimmune hepatitis in adolescence and early adulthood. Hepatology Research 2009;39:766-71. [DOI: 10.1111/j.1872-034x.2009.00510.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
184 Della Corte C, Sartorelli MR, Sindoni CD, Girolami E, Giovannelli L, Comparcola D, Nobili V. Autoimmune hepatitis in children: an overview of the disease focusing on current therapies. European Journal of Gastroenterology & Hepatology 2012;24:739-46. [DOI: 10.1097/meg.0b013e328353750c] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
185 Eren E, Özkan TB, Çakır ED, Sağlam H, Tarım Ö. Acquired generalized lipodystrophy associated with autoimmune hepatitis and low serum C4 level. J Clin Res Pediatr Endocrinol 2010;2:39-42. [PMID: 21274335 DOI: 10.4274/jcrpe.v2i1.39] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
186 Venkatasubramani N, Szabo S, Werlin SL. Autoimmune hepatitis in a child with chronic hepatitis B virus infection. J Pediatr Gastroenterol Nutr. 2009;49:639-641. [PMID: 19561549 DOI: 10.1097/MPG.0b013e3181903fbd] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
187 Fabien N, Desbos A, Bienvenu J, Magdalou J. Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis. Autoimmun Rev. 2004;3:1-9. [PMID: 14871643 DOI: 10.1016/s1568-9972(03)00051-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
188 Gargouri L, Mnif L, Safi F, Turki F, Majdoub I, Maalej B, Bahri I, Mnif H, Boudawara T, Tahri N, Mahfoudh A. Type 2 autoimmune hepatitis overlapping with primary sclerosing cholangitis in a 10-year-old boy. Arch Pediatr. 2013;20:1325-1328. [PMID: 24182664 DOI: 10.1016/j.arcped.2013.09.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
189 Odineal DD, Gershwin ME. The Epidemiology and Clinical Manifestations of Autoimmunity in Selective IgA Deficiency. Clin Rev Allergy Immunol 2020;58:107-33. [PMID: 31267472 DOI: 10.1007/s12016-019-08756-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 16.0] [Reference Citation Analysis]
190 Mavis AM, Alonso EM. Liver disease in the adolescent. Clin Liver Dis 2015;19:171-85. [PMID: 25454303 DOI: 10.1016/j.cld.2014.09.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
191 Takai S, Inoue J, Kogure T, Kakazu E, Ninomiya M, Iwata T, Umetsu T, Nakamura T, Sano A, Shimosegawa T. Acute-onset Autoimmune Hepatitis in a Young Woman with Type 1 Diabetes Mellitus. Intern Med 2018;57:1591-6. [PMID: 29321432 DOI: 10.2169/internalmedicine.9728-17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
192 Mieli-vergani G, Vergani D, Baumann U, Czubkowski P, Debray D, Dezsofi A, Fischler B, Gupte G, Hierro L, Indolfi G, Jahnel J, Smets F, Verkade HJ, Hadžić N. Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement. Journal of Pediatric Gastroenterology & Nutrition 2018;66:345-60. [DOI: 10.1097/mpg.0000000000001801] [Cited by in Crossref: 100] [Cited by in F6Publishing: 20] [Article Influence: 33.3] [Reference Citation Analysis]
193 Deneau M, Book LS, Guthery SL, Jensen MK. Outcome after Discontinuation of Immunosuppression in Children with Autoimmune Hepatitis: A Population-Based Study. The Journal of Pediatrics 2014;164:714-719.e2. [DOI: 10.1016/j.jpeds.2013.12.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
194 Zhu B, You SL, Wan ZH, Liu HL, Rong YH, Zang H, Xin SJ. Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure. World J Gastroenterol 2014;20:7473-9. [PMID: 24966618 DOI: 10.3748/wjg.v20.i23.7473] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
195 White FV, Dehner LP. Viral diseases of the liver in children: diagnostic and differential diagnostic considerations. Pediatr Dev Pathol 2004;7:552-67. [PMID: 15630523 DOI: 10.1007/s10024-004-8101-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
196 Kerkar N, Ma Y, Davies ET, Cheeseman P, Mieli-Vergani G, Vergani D. Detection of liver kidney microsomal type 1 antibody using molecularly based immunoassays. J Clin Pathol 2002;55:906-9. [PMID: 12461054 DOI: 10.1136/jcp.55.12.906] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
197 Yassin S, De Lacy R, Pillay K, Goddard E. Characteristics and Outcomes of Autoimmune Hepatitis from a Tertiary Paediatric Centre, Cape Town, South Africa. J Trop Pediatr 2020;66:448-57. [PMID: 31943108 DOI: 10.1093/tropej/fmz088] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Muratori L, Granito A, Muratori P, Pappas G, Bianchi FB. Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin Liver Dis. 2008;12:261-276; vii. [PMID: 18456179 DOI: 10.1016/j.cld.2008.02.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
199 Sebode M, Schulz L, Lohse AW. "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis. Int J Mol Sci 2017;18:E1954. [PMID: 28895915 DOI: 10.3390/ijms18091954] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
200 Vogel A, Wedemeyer H, P Manns M, Strassburg CP. Autoimmune hepatitis and overlap syndromes: Autoimmune hepatitis and overlap syndromes. Journal of Gastroenterology and Hepatology 2002;17:S389-98. [DOI: 10.1046/j.1440-1746.17.s3.33.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
201 Abdollahi M, Ekrami NK, Ghojazadeh M, Boezen HM, Somi M, Alizadeh BZ. Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations? World J Gastroenterol 2020;26:5896-910. [PMID: 33132643 DOI: 10.3748/wjg.v26.i38.5896] [Reference Citation Analysis]
202 Martin SR, Alvarez F, Anand R, Song C, Yin W. Outcomes in children who underwent transplantation for autoimmune hepatitis. Liver Transpl. 2011;17:393-401. [PMID: 21445922 DOI: 10.1002/lt.22244] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
203 West M, Jasin HE, Medhekar S. The development of connective tissue diseases in patients with autoimmune hepatitis: a case series. Semin Arthritis Rheum. 2006;35:344-348. [PMID: 16765710 DOI: 10.1016/j.semarthrit.2005.12.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
204 Lankisch TO, Strassburg CP, Debray D, Manns MP, Jacquemin E. Detection of Autoimmune Regulator Gene Mutations in Children with Type 2 Autoimmune Hepatitis and Extrahepatic Immune-mediated Diseases. The Journal of Pediatrics 2005;146:839-42. [DOI: 10.1016/j.jpeds.2005.01.050] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
205 Richardson N, Ng STH, Wraith DC. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases. Front Immunol 2020;11:1586. [PMID: 32793226 DOI: 10.3389/fimmu.2020.01586] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
206 Rigopoulou EI, Dalekos G, Bogdanos DP. How common are connective tissue disorders in patients with autoimmune hepatitis? Semin Arthritis Rheum. 2007;36:332; author reply 333. [PMID: 17276497 DOI: 10.1016/j.semarthrit.2006.11.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
207 Terziroli Beretta-piccoli B, Mieli-vergani G, Vergani D. Serology in autoimmune hepatitis: A clinical-practice approach. European Journal of Internal Medicine 2018;48:35-43. [DOI: 10.1016/j.ejim.2017.10.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
208 Vitfell-Pedersen J, Jørgensen MH, Müller K, Heilmann C. Autoimmune hepatitis in children in Eastern Denmark. J Pediatr Gastroenterol Nutr. 2012;55:376-379. [PMID: 22644464 DOI: 10.1097/mpg.0b013e3182602b20] [Cited by in Crossref: 24] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
209 Dumortier J, Arita CT, Rivet C, LeGall C, Bouvier R, Fabien N, Guillaud O, Collardeau-Frachon S, Scoazec JY, Lachaux A. Long-term treatment reduction and steroids withdrawal in children with autoimmune hepatitis: a single centre experience on 55 children. Eur J Gastroenterol Hepatol. 2009;21:1413-1418. [PMID: 19907227 DOI: 10.1097/meg.0b013e32832ad5f7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
210 Mackay IR. Autoimmune disease overlaps and the liver: Two for the price of one? Journal of Gastroenterology and Hepatology 2001;15:3-8. [DOI: 10.1046/j.1440-1746.2000.02041.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
211 Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol. 2004;41:31-37. [PMID: 15246204 DOI: 10.1016/j.jhep.2004.03.008] [Cited by in Crossref: 271] [Cited by in F6Publishing: 240] [Article Influence: 16.9] [Reference Citation Analysis]
212 Heneghan MA, Yeoman AD, Verma S, Smith AD, Longhi MS. Autoimmune hepatitis. Lancet. 2013;382:1433-1444. [PMID: 23768844 DOI: 10.1016/s0140-6736(12)62163-1] [Cited by in Crossref: 143] [Cited by in F6Publishing: 56] [Article Influence: 17.9] [Reference Citation Analysis]
213 Agrawal S, Prakash S. Significance of KIR like natural killer cell receptors in autoimmune disorders. Clin Immunol 2020;216:108449. [PMID: 32376502 DOI: 10.1016/j.clim.2020.108449] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
214 Hadzic N, Hierro L. Autoimmune liver disease: novelties in management. Clin Res Hepatol Gastroenterol. 2014;38:273-276. [PMID: 24767608 DOI: 10.1016/j.clinre.2014.03.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
215 Fathalla BM, Goldsmith DP, Pascasio JM, Baldridge A. Development of autoimmune hepatitis in a child with systemic-onset juvenile idiopathic arthritis during therapy with etanercept. J Clin Rheumatol. 2008;14:297-298. [PMID: 18824922 DOI: 10.1097/rhu.0b013e318188b1df] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
216 Vergani D, Mieli-Vergani G. Pharmacological management of autoimmune hepatitis. Expert Opin Pharmacother. 2011;12:607-613. [PMID: 21235284 DOI: 10.1517/14656566.2011.524206] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
217 Cuarterolo ML, Ciocca ME, López SI, de Dávila MT, Álvarez F. Immunosuppressive Therapy Allows Recovery From Liver Failure in Children With Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 2011;9:145-149.e1. [DOI: 10.1016/j.cgh.2010.10.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
218 Dalekos GN, Zachou K, Liaskos C, Gatselis N. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview. Eur J Intern Med. 2002;13:293-303. [PMID: 12144908 DOI: 10.1016/s0953-6205(02)00089-4] [Cited by in Crossref: 63] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
219 Tenca A, Färkkilä M, Jalanko H, Vapalahti K, Arola J, Jaakkola T, Penagini R, Vapalahti O, Kolho KL. Environmental Risk Factors of Pediatric-Onset Primary Sclerosing Cholangitis and Autoimmune Hepatitis. J Pediatr Gastroenterol Nutr 2016;62:437-42. [PMID: 26465796 DOI: 10.1097/MPG.0000000000000995] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
220 Cicalese MP, Iorio R. Management of Autoimmune Hepatitis in Children: How Many Steps Away From Common Agreement? Journal of Pediatric Gastroenterology & Nutrition 2012;55:364. [DOI: 10.1097/mpg.0b013e3182602b3b] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
221 Fallatah HI, Akbar HO. Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview. Autoimmune Dis. 2012;2012:312817. [PMID: 23304455 DOI: 10.1155/2012/312817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
222 Czaja AJ. Autoimmune hepatitis in diverse ethnic populations and geographical regions. Expert Rev Gastroenterol Hepatol. 2013;7:365-385. [PMID: 23639095 DOI: 10.1586/egh.13.21] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
223 Longhi MS, Ma Y, Mitry RR, Bogdanos DP, Heneghan M, Cheeseman P, Mieli-Vergani G, Vergani D. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun. 2005;25:63-71. [PMID: 16005184 DOI: 10.1016/j.jaut.2005.05.001] [Cited by in Crossref: 148] [Cited by in F6Publishing: 134] [Article Influence: 9.3] [Reference Citation Analysis]
224 Zachou K, Rigopoulou E, Dalekos GN. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis 2004;1:2. [PMID: 15679907 DOI: 10.1186/1740-2557-1-2] [Cited by in Crossref: 89] [Cited by in F6Publishing: 73] [Article Influence: 5.2] [Reference Citation Analysis]
225 Kage M. Pathology of autoimmune liver diseases in children. Hepatol Res 2007;37 Suppl 3:S502-8. [PMID: 17931211 DOI: 10.1111/j.1872-034X.2007.00234.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
226 Bellomo-brandão MA, Costa-pinto EALD, Tommaso AMAD, Hessel G. Clinical and biochemical features of autoimmune hepatitis in 36 pediatric patients. Arq Gastroenterol 2006;43:45-9. [DOI: 10.1590/s0004-28032006000100012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
227 Mieli-Vergani G, Vergani D. Autoimmune liver disease. Indian J Pediatr 2002;69:93-8. [PMID: 11876129 DOI: 10.1007/BF02723785] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
228 Li X, Chen H, Cai Y, Zhang P, Chen Z. Association of STAT4 and PTPN22 polymorphisms and their interactions with type-1 autoimmune hepatitis susceptibility in Chinese Han children. Oncotarget 2017;8:60933-40. [PMID: 28977835 DOI: 10.18632/oncotarget.17458] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
229 Oo YH, Neuberger J. Use of mycophenolate in the treatment of autoimmune hepatitis. Liver Int 2005;25:687-91. [DOI: 10.1111/j.1478-3231.2005.01123.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
230 Jain V, Srivastava A, Yachha SK, Kumari N, Kathuria R, Sarma MS, Poddar U, Krishnani N. Autoimmune acute liver failure and seronegative autoimmune liver disease in children: Are they different from classical disease? Eur J Gastroenterol Hepatol 2017;29:1408-15. [PMID: 28914695 DOI: 10.1097/MEG.0000000000000975] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
231 Mieli-vergani G, Bargiota K, Samyn M, Vergani D. Therapeutic aspects of autoimmune liver disease in children. In: Dienes H-, Leuschner U, Lohse AW, Manns MP, editors. Autoimmune Liver Disease. Dordrecht: Springer Netherlands; 2005. pp. 278-82. [DOI: 10.1007/1-4020-2914-4_25] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
232 Zheng MH, Gu DN, Braddock M, Leishman AJ, Jin C, Wen JS, Gong YW, Chen YP. CD4+ CD25+ regulatory T cells: a therapeutic target for liver diseases. Expert Opin Ther Targets. 2008;12:313-326. [PMID: 18269341 DOI: 10.1517/14728222.12.3.313] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
233 Mackay IR. HEPATIC DISEASE AND SYSTEMIC LUPUS ERYTHEMATOSUS: COINCIDENCE OR CONVERGENCE. Systemic Lupus Erythematosus. Elsevier; 2004. pp. 993-1017. [DOI: 10.1016/b978-012433901-9/50038-7] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
234 Mieli-Vergani G, Vergani D. Autoimmune hepatitis in childhood. Clin Liver Dis (Hoboken) 2014;3:6-8. [PMID: 30992879 DOI: 10.1002/cld.296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
235 Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. J Hepatol. 2000;32:181-197. [PMID: 10728804 DOI: 10.1016/s0168-8278(00)80425-0] [Cited by in Crossref: 124] [Cited by in F6Publishing: 22] [Article Influence: 5.9] [Reference Citation Analysis]
236 Saadah OI, Khayat A, Alsufyani HA, Bin-Taleb Y. Paediatric autoimmune liver diseases: A descriptive study of patients from Saudi Arabia. Arab J Gastroenterol 2021;22:146-50. [PMID: 34059447 DOI: 10.1016/j.ajg.2021.05.009] [Reference Citation Analysis]
237 Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, Vierling JM, Alsawas M, Murad MH, Czaja AJ. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology. 2020;72:671-722. [PMID: 31863477 DOI: 10.1002/hep.31065] [Cited by in Crossref: 104] [Cited by in F6Publishing: 75] [Article Influence: 104.0] [Reference Citation Analysis]
238 Raquel Benedita Terrabuio D, Augusto Diniz M, Teofilo de Moraes Falcão L, Luiza Vilar Guedes A, Akeme Nakano L, Silva Evangelista A, Roberto Lima F, Pires Abrantes-Lemos C, José Carrilho F, Luiz Rachid Cancado E. Chloroquine Is Effective for Maintenance of Remission in Autoimmune Hepatitis: Controlled, Double-Blind, Randomized Trial. Hepatol Commun 2019;3:116-28. [PMID: 30619999 DOI: 10.1002/hep4.1275] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
239 Deneau M, Jensen MK, Holmen J, Williams MS, Book LS, Guthery SL. Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology. 2013;58:1392-1400. [PMID: 23686586 DOI: 10.1002/hep.26454] [Cited by in Crossref: 130] [Cited by in F6Publishing: 82] [Article Influence: 16.3] [Reference Citation Analysis]
240 Hunt A, Tasker RC, Deep A. Neurocritical care monitoring of encephalopathic children with acute liver failure: A systematic review. Pediatr Transplant 2019;23:e13556. [PMID: 31407855 DOI: 10.1111/petr.13556] [Reference Citation Analysis]
241 Lohse AW, Mieli-Vergani G. Autoimmune hepatitis. J Hepatol. 2011;55:171-182. [PMID: 21167232 DOI: 10.1016/j.jhep.2010.12.012] [Cited by in Crossref: 121] [Cited by in F6Publishing: 87] [Article Influence: 11.0] [Reference Citation Analysis]
242 Czaja AJ. Autoimmune hepatitis. Part A: pathogenesis. Expert Rev Gastroenterol Hepatol. 2007;1:113-128. [PMID: 19072440 DOI: 10.1586/17474124.1.1.113] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
243 Vergani D, Choudhuri K, Bogdanos DP, Mieli-Vergani G. Pathogenesis of autoimmune hepatitis. Clin Liver Dis. 2002;6:727-737. [PMID: 12362577 DOI: 10.1016/s1089-3261(02)00018-1] [Cited by in Crossref: 103] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
244 Czaja AJ. Animal models of autoimmune hepatitis. Expert Rev Gastroenterol Hepatol. 2010;4:429-443. [PMID: 20678017 DOI: 10.1586/egh.10.42] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
245 Goeldner I, Skare TL, de Messias Reason IT, Nisihara RM, Silva MB, da Rosa Utiyama SR. Autoantibodies for gastrointestinal organ-specific autoimmune diseases in rheumatoid arthritis patients and their relatives. Clin Rheumatol 2011;30:99-102. [DOI: 10.1007/s10067-010-1540-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
246 Durazzo M, Premoli A, Fagoonee S, Pellicano R. Overlap syndromes of autoimmune hepatitis: what is known so far. Dig Dis Sci 2003;48:423-30. [PMID: 12757152 DOI: 10.1023/a:1022597210629] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
247 van den Brand FF, van der Veen KS, de Boer YS, van Gerven NM, Lissenberg-Witte BI, Beuers U, van Erpecum KJ, van Buuren HR, den Ouden JW, Brouwer JT, Vrolijk JM, Verdonk RC, van Hoek B, Koek GH, Drenth JPH, Guichelaar MMJ, Mulder CJJ, Bloemena E, van Nieuwkerk CMJ, Bouma G; Dutch Autoimmune Hepatitis Study Group. Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis. Clin Gastroenterol Hepatol. 2019;17:940-947.e2. [PMID: 30291909 DOI: 10.1016/j.cgh.2018.09.046] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 7.3] [Reference Citation Analysis]
248 Guo J, Shirozu K, Akahoshi T, Mizuta Y, Murata M, Yamaura K. The farnesyltransferase inhibitor tipifarnib protects against autoimmune hepatitis induced by Concanavalin A. Int Immunopharmacol 2020;83:106462. [PMID: 32251961 DOI: 10.1016/j.intimp.2020.106462] [Reference Citation Analysis]
249 Haas S, Bindl L, Fischer H. Autoimmune enteric leiomyositis: A rare cause of chronic intestinal pseudo-obstruction with specific morphological features. Human Pathology 2005;36:576-80. [DOI: 10.1016/j.humpath.2005.01.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
250 Zellos A, Spoulou V, Roma-Giannikou E, Karentzou O, Dalekos GN, Theodoridou M. Autoimmune hepatitis type-2 and Epstein-Barr virus infection in a toddler: art of facts or an artifact? Ann Hepatol. 2013;12:147-151. [PMID: 23293207 DOI: 10.1016/s1665-2681(19)31398-5] [Cited by in Crossref: 13] [Article Influence: 1.6] [Reference Citation Analysis]
251 Porta G, de Carvalho E, Santos JL, Gama J, Bezerra JA; Brazilian Group for the Study of Pediatric Liver Diseases. Autoimmune Hepatitis: Predictors of Native Liver Survival in Children and Adolescents. J Pediatr 2021;229:95-101.e3. [PMID: 33500120 DOI: 10.1016/j.jpeds.2020.10.009] [Reference Citation Analysis]
252 Mohammad S. Budesonide as first-line therapy for non-cirrhotic autoimmune hepatitis in children: a decision analysis. Scandinavian Journal of Gastroenterology 2016;51:753-62. [DOI: 10.3109/00365521.2015.1130166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
253 Manns MP, Vogel A. Autoimmune hepatitis, from mechanisms to therapy. Hepatology. 2006;43:S132-S144. [PMID: 16447290 DOI: 10.1002/hep.21059] [Cited by in Crossref: 118] [Cited by in F6Publishing: 91] [Article Influence: 7.9] [Reference Citation Analysis]
254 Manns MP, Strassburg CP. Autoimmune hepatitis: Clinical challenges. Gastroenterology 2001;120:1502-17. [DOI: 10.1053/gast.2001.24227] [Cited by in Crossref: 153] [Cited by in F6Publishing: 103] [Article Influence: 7.7] [Reference Citation Analysis]
255 Czaja AJ, Doherty DG, Donaldson PT. Genetic bases of autoimmune hepatitis. Dig Dis Sci. 2002;47:2139-2150. [PMID: 12395884 DOI: 10.1023/a:1020166605016] [Cited by in Crossref: 74] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
256 Liberal R, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: From mechanisms to therapy. Rev Clin Esp. 2016;216:372-383. [PMID: 27161382 DOI: 10.1016/j.rce.2016.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
257 Miyagawa-hayashino A, Haga H, Egawa H, Hayashino Y, Sakurai T, Minamiguchi S, Tanaka K, Manabe T. Outcome and Risk Factors of De Novo Autoimmune Hepatitis in Living-Donor Liver Transplantation. Transplantation 2004;78:128-35. [DOI: 10.1097/01.tp.0000132328.33460.43] [Cited by in Crossref: 83] [Cited by in F6Publishing: 10] [Article Influence: 4.9] [Reference Citation Analysis]
258 Strassburg CP, Manns MP. Therapy of autoimmune hepatitis. Best Pract Res Clin Gastroenterol. 2011;25:673-687. [PMID: 22117634 DOI: 10.1016/j.bpg.2011.08.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
259 Montano-Loza AJ, Thandassery RB, Czaja AJ. Targeting Hepatic Fibrosis in Autoimmune Hepatitis. Dig Dis Sci. 2016;61:3118-3139. [PMID: 27435327 DOI: 10.1007/s10620-016-4254-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
260 Baker A, Dhawan A, Heaton N. Who needs a liver transplant? (new disease specific indications). Arch Dis Child 1998;79:460-4. [PMID: 10193265 DOI: 10.1136/adc.79.5.460] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
261 Wiegand J, Schüler A, Kanzler S, Lohse A, Beuers U, Kreisel W, Spengler U, Koletzko S, Jansen PL, Hochhaus G, Möllmann HW, Pröls M, Manns MP. Budesonide in previously untreated autoimmune hepatitis. Liver Int 2005;25:927-34. [PMID: 16162148 DOI: 10.1111/j.1478-3231.2005.01122.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 55] [Article Influence: 4.3] [Reference Citation Analysis]
262 Gerussi A, Halliday N, Saffioti F, Bernasconi DP, Roccarina D, Marshall A, Thorburn D. Normalization of serum immunoglobulin G levels is associated with improved transplant-free survival in patients with autoimmune hepatitis. Digestive and Liver Disease 2020;52:761-7. [DOI: 10.1016/j.dld.2020.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
263 Yeoman AD, Westbrook RH, Zen Y, Maninchedda P, Portmann BC, Devlin J, O'Grady JG, Harrison PM, Heneghan MA. Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis. Hepatology. 2011;53:926-934. [PMID: 21374663 DOI: 10.1002/hep.24141] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 6.8] [Reference Citation Analysis]
264 Al-Khalidi JA, Czaja AJ. Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis. Mayo Clin Proc. 2001;76:1237-1252. [PMID: 11761505 DOI: 10.4065/76.12.1237] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
265 Mieli-Vergani G, Heller S, Jara P, Vergani D, Chang MH, Fujisawa T, González-Peralta RP, Kelly D, Mohan N, Shah U. Autoimmune hepatitis. J Pediatr Gastroenterol Nutr. 2009;49:158-164. [PMID: 19561543 DOI: 10.1097/mpg.0b013e3181a1c265] [Cited by in Crossref: 119] [Cited by in F6Publishing: 23] [Article Influence: 9.9] [Reference Citation Analysis]
266 Floreani A, Liberal R, Vergani D, Mieli-Vergani G. Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review. J Autoimmun. 2013;46:7-16. [PMID: 24035197 DOI: 10.1016/j.jaut.2013.08.004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 50] [Article Influence: 8.9] [Reference Citation Analysis]
267 Liberal R, Krawitt EL, Vierling JM, Manns MP, Mieli-Vergani G, Vergani D. Cutting edge issues in autoimmune hepatitis. J Autoimmun. 2016;75:6-19. [PMID: 27502148 DOI: 10.1016/j.jaut.2016.07.005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 11.6] [Reference Citation Analysis]
268 Alvarez F, Ciocca M, Cañero-Velasco C, Ramonet M, de Davila MT, Cuarterolo M, Gonzalez T, Jara-Vega P, Camarena C, Brochu P, Drut R, Alvarez E. Short-term cyclosporine induces a remission of autoimmune hepatitis in children. J Hepatol 1999;30:222-7. [PMID: 10068099 DOI: 10.1016/s0168-8278(99)80065-8] [Cited by in Crossref: 146] [Cited by in F6Publishing: 22] [Article Influence: 6.6] [Reference Citation Analysis]
269 Hadžić N, Baumann U, Mckiernan P, Mclin V, Nobili V. Long-term challenges and perspectives of pre-adolescent liver disease. The Lancet Gastroenterology & Hepatology 2017;2:435-45. [DOI: 10.1016/s2468-1253(16)30160-1] [Cited by in Crossref: 8] [Article Influence: 2.0] [Reference Citation Analysis]
270 da Silva ME, Porta G, Goldberg AC, Bittencourt PL, Fukui RT, Correia MR, Miura IK, Pugliese RS, Baggio VL, Cançado EL, Kalil J, Santos RF, Rochal DM, Wajchenberg BL, Ursich MJ, Rosenbloom AL. Diabetes mellitus-related autoantibodies in childhood autoimmune hepatitis. J Pediatr Endocrinol Metab 2002;15:831-40. [PMID: 12099394 DOI: 10.1515/jpem.2002.15.6.831] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
271 Mieli-Vergani G, Vergani D. Budesonide for juvenile autoimmune hepatitis? Not yet. J Pediatr. 2013;163:1246-1248. [PMID: 23932214 DOI: 10.1016/j.jpeds.2013.06.064] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
272 Hyams JS. Corticosteroids in the treatment of gastrointestinal disease: . Current Opinion in Pediatrics 2000;12:451-5. [DOI: 10.1097/00008480-200010000-00005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
273 Villalta D, Girolami E, Alessio MG, Sorrentino MC, Tampoia M, Brusca I, Daves M, Porcelli B, Barberio G, Conte M, Pantarotto L, Bizzaro N; Study Group on Autoimmune Diseases of the Italian Society of Laboratory Medicine, Italy. Autoantibody Profiling in a Cohort of Pediatric and Adult Patients With Autoimmune Hepatitis. J Clin Lab Anal 2016;30:41-6. [PMID: 25242745 DOI: 10.1002/jcla.21813] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
274 Liberal R, Grant CR. Cirrhosis and autoimmune liver disease: Current understanding. World J Hepatol 2016;8:1157-68. [PMID: 27729952 DOI: 10.4254/wjh.v8.i28.1157] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
275 Liberal R, Grant CR, Longhi MS, Mieli-Vergani G, Vergani D. Diagnostic criteria of autoimmune hepatitis. Autoimmun Rev. 2014;13:435-440. [PMID: 24418295 DOI: 10.1016/j.autrev.2013.11.009] [Cited by in Crossref: 73] [Cited by in F6Publishing: 48] [Article Influence: 10.4] [Reference Citation Analysis]
276 Mieli-vergani G, Vergani D. Autoimmune hepatitis. Nat Rev Gastroenterol Hepatol 2011;8:320-9. [DOI: 10.1038/nrgastro.2011.69] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 7.3] [Reference Citation Analysis]
277 Czaja AJ. Mycophenolate mofetil to the rescue in autoimmune hepatitis: a fresh sprout on the decision tree. J Hepatol 2009;51:8-10. [PMID: 19446910 DOI: 10.1016/j.jhep.2009.03.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
278 Roberts EA. Autoimmune hepatitis from the paediatric perspective. Liver International 2011;31:1424-31. [DOI: 10.1111/j.1478-3231.2011.02603.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
279 Aydemir Y, Akcoren Z, Demir H, Saltik Temizel IN, Ozen H, Yuce A. Clinical and histopathological features of immunoglobulin G4‐associated autoimmune hepatitis in children. Journal of Gastroenterology and Hepatology 2019;34:742-6. [DOI: 10.1111/jgh.14525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
280 Brown SA, Axenfeld E, Stonesifer EG, Hutson W, Hanish S, Raufman J, Urrunaga NH. Current and prospective therapies for acute liver failure. Disease-a-Month 2018;64:493-522. [DOI: 10.1016/j.disamonth.2018.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
281 Perreaux F, Zenaty D, Capron F, Trioche P, Odi??vre M, Labrune P. Azathioprine-Induced Lung Toxicity and Efficacy of Cyclosporin A in a Young Girl With Type 2 Autoimmune Hepatitis: . Journal of Pediatric Gastroenterology and Nutrition 2000;31:190-2. [DOI: 10.1097/00005176-200008000-00020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
282 Strassburg CP, Manns MP. Transition of care between paediatric and adult gastroenterology. Autoimmune hepatitis. Best Pract Res Clin Gastroenterol 2003;17:291-306. [PMID: 12676120 DOI: 10.1016/s1521-6918(03)00015-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
283 Bittencourt PL, Farias AQ, Porta G, Cançado EL, Miura I, Pugliese R, Kalil J, Goldberg AC, Carrilho FJ. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background. J Clin Gastroenterol 2008;42:300-5. [PMID: 18223493 DOI: 10.1097/MCG.0b013e31802dbdfc] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
284 Malik N, Venkatesh SK. Imaging of autoimmune hepatitis and overlap syndromes. Abdom Radiol (NY). 2017;42:19-27. [PMID: 27999888 DOI: 10.1007/s00261-016-1019-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
285 Palle SK, Naik KB, McCracken CE, Kolachala VL, Romero R, Gupta NA. Racial disparities in presentation and outcomes of paediatric autoimmune hepatitis. Liver Int 2019;39:976-84. [PMID: 30802337 DOI: 10.1111/liv.14081] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
286 Montano Loza AJ, Czaja AJ. Current therapy for autoimmune hepatitis. Nat Rev Gastroenterol Hepatol 2007;4:202-14. [DOI: 10.1038/ncpgasthep0768] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
287 Dyson JK, Wong LL, Bigirumurame T, Hirschfield GM, Kendrick S, Oo YH, Lohse AW, Heneghan MA, Jones DEJ; UK-AIH Consortium. Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom. Aliment Pharmacol Ther 2018;48:951-60. [PMID: 30226274 DOI: 10.1111/apt.14968] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
288 Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Bansal S, Longhi MS, Cheeseman P, Mieli-Vergani G, Vergani D. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology. 2006;130:868-882. [PMID: 16530525 DOI: 10.1053/j.gastro.2005.12.020] [Cited by in Crossref: 138] [Cited by in F6Publishing: 113] [Article Influence: 9.2] [Reference Citation Analysis]
289 Bogdanos D, Mieli-vergani G, Vergani D. Liver-kidney microsomal antibody-positive autoimmune hepatitis in the United States. Am J Gastroenterology 2001;96:3447-8. [DOI: 10.1111/j.1572-0241.2001.05382.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
290 Dhiman P, Malhotra S. Overlap syndromes: an emerging diagnostic and therapeutic challenge. Saudi J Gastroenterol 2014;20:342-9. [PMID: 25434314 DOI: 10.4103/1319-3767.145316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
291 Sipe WEB, Su M, Posselt A, Kim GE, Quiros JA, Rosenthal P. Propylthiouracil-associated liver failure presenting as probable autoimmune hepatitis in a child with Graves' disease. Pediatric Transplantation 2006;10:525-8. [DOI: 10.1111/j.1399-3046.2006.00487.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
292 Squires RH, Ng V, Romero R, Ekong U, Hardikar W, Emre S, Mazariegos GV. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology. 2014;60:362-398. [PMID: 24782219 DOI: 10.1002/hep.27191] [Cited by in Crossref: 101] [Cited by in F6Publishing: 63] [Article Influence: 14.4] [Reference Citation Analysis]
293 Buuren HR, Hoogstraten HJ, Terkivatan T, Schalm SW, Vleggaar FP. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. Journal of Hepatology 2000;33:543-8. [DOI: 10.1016/s0168-8278(00)80005-7] [Cited by in Crossref: 17] [Article Influence: 0.8] [Reference Citation Analysis]
294 Czaja AJ. Treatment strategies in autoimmune hepatitis. Clinics in Liver Disease 2002;6:799-824. [DOI: 10.1016/s1089-3261(02)00028-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
295 Zheng L, Liu Y, Shang Y, Han Z, Han Y. Clinical characteristics and treatment outcomes of acute severe autoimmune hepatitis. BMC Gastroenterol 2021;21:93. [PMID: 33648445 DOI: 10.1186/s12876-021-01653-4] [Reference Citation Analysis]
296 Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World J Gastroenterol 2017;23:6030-48. [PMID: 28970719 DOI: 10.3748/wjg.v23.i33.6030] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 33] [Article Influence: 14.7] [Reference Citation Analysis]
297 Joshi D, Gupta N, Samyn M, Deheragoda M, Dobbels F, Heneghan MA. The management of childhood liver diseases in adulthood. Journal of Hepatology 2017;66:631-44. [DOI: 10.1016/j.jhep.2016.11.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
298 Czaja AJ. Transitioning from Idiopathic to Explainable Autoimmune Hepatitis. Dig Dis Sci. 2015;60:2881-2900. [PMID: 25999246 DOI: 10.1007/s10620-015-3708-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
299 Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, Lohse AW, Montano-Loza AJ. Autoimmune hepatitis. Nat Rev Dis Primers. 2018;4:18017. [PMID: 29644994 DOI: 10.1038/nrdp.2018.17] [Cited by in Crossref: 92] [Cited by in F6Publishing: 67] [Article Influence: 30.7] [Reference Citation Analysis]
300 Longhi MS, Ma Y, Grant CR, Samyn M, Gordon P, Mieli-Vergani G, Vergani D. T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile. J Autoimmun. 2013;41:146-151. [PMID: 23287048 DOI: 10.1016/j.jaut.2012.12.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
301 Ferreira AR, Roquete ML, Toppa NH, de Castro LP, Fagundes ED, Penna FJ. Effect of treatment of hepatic histopathology in children and adolescents with autoimmune hepatitis. J Pediatr Gastroenterol Nutr. 2008;46:65-70. [PMID: 18162836 DOI: 10.1097/01.mpg.0000304456.84552.13] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
302 Önder FO, Yürekli ÖT, Öztaş E, Kalkan İH, Köksal AŞ, Akdoğan M, Şaşmaz N, Kayaçetin E. Features of systemic lupus erythematosus in patients with autoimmune hepatitis. Rheumatol Int 2013;33:1581-5. [DOI: 10.1007/s00296-012-2607-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
303 Parker R, Oo YH, Adams DH. Management of patients with difficult autoimmune hepatitis. Therap Adv Gastroenterol. 2012;5:421-437. [PMID: 23152735 DOI: 10.1177/1756283X12450251] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
304 Mieli-Vergani G, Vergani D. Autoimmune liver diseases in children - what is different from adulthood? Best Pract Res Clin Gastroenterol. 2011;25:783-795. [PMID: 22117642 DOI: 10.1016/j.bpg.2011.10.007] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
305 Liberal R, Grant CR, Holder BS, Cardone J, Martinez-llordella M, Ma Y, Heneghan MA, Mieli-vergani G, Vergani D, Longhi MS. In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression: HEPATOLOGY, Vol. XX, No. X, 2015. Hepatology 2015;62:863-75. [DOI: 10.1002/hep.27884] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 9.3] [Reference Citation Analysis]
306 Di Giorgio A, Hadzic N, Dhawan A, Deheragoda M, Heneghan MA, Vergani D, Mieli-vergani G, Samyn M. Seamless Management of Juvenile Autoimmune Liver Disease: Long-Term Medical and Social Outcome. The Journal of Pediatrics 2020;218:121-129.e3. [DOI: 10.1016/j.jpeds.2019.11.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
307 Vergani D, Alvarez F, Bianchi FB, Cançado EL, Mackay IR, Manns MP, Nishioka M, Penner E. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol. 2004;41:677-683. [PMID: 15464251 DOI: 10.1016/j.jhep.2004.08.002] [Cited by in Crossref: 269] [Cited by in F6Publishing: 203] [Article Influence: 16.8] [Reference Citation Analysis]
308 Vergani D, Mieli-Vergani G. Cutting edge issues in autoimmune hepatitis. Clin Rev Allergy Immunol. 2012;42:309-321. [PMID: 21207191 DOI: 10.1007/s12016-010-8236-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
309 Potts JR, Verma S. Optimizing management in autoimmune hepatitis with liver failure at initial presentation. World J Gastroenterol 2011;17:2070-5. [PMID: 21547124 DOI: 10.3748/wjg.v17.i16.2070] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
310 Liberal R, Gaspar R, Lopes S, Macedo G. Long-term outcome of patients with difficult-to-treat autoimmune hepatitis receiving mycophenolate mofetil. Clin Res Hepatol Gastroenterol 2021;45:101487. [PMID: 32651078 DOI: 10.1016/j.clinre.2020.06.013] [Reference Citation Analysis]
311 Rigopoulou EI, Roggenbuck D, Smyk DS, Liaskos C, Mytilinaiou MG, Feist E, Conrad K, Bogdanos DP. Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found. Autoimmun Rev. 2012;12:260-269. [PMID: 22571878 DOI: 10.1016/j.autrev.2012.04.005] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
312 Ylinen E, Salmela L, Peräsaari J, Jaatinen T, Tenca A, Vapalahti O, Färkkilä M, Jalanko H, Kolho K. Human leucocyte antigens B*08 , DRB1*03 and DRB1*13 are significantly associated with autoimmune liver and biliary diseases in Finnish children. Acta Paediatr 2017;106:322-6. [DOI: 10.1111/apa.13641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
313 Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, Dhawan A, Rosenthal P, Rodriguez-Baez N, Murray KF, Horslen S, Martin MG, Lopez MJ, Soriano H, McGuire BM, Jonas MM, Yazigi N, Shepherd RW, Schwarz K, Lobritto S, Thomas DW, Lavine JE, Karpen S, Ng V, Kelly D, Simonds N, Hynan LS. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652-658. [PMID: 16737880 DOI: 10.1016/j.jpeds.2005.12.051] [Cited by in Crossref: 467] [Cited by in F6Publishing: 296] [Article Influence: 31.1] [Reference Citation Analysis]
314 Muratori P, Lalanne C, Barbato E, Fabbri A, Cassani F, Lenzi M, Muratori L. Features and Progression of Asymptomatic Autoimmune Hepatitis in Italy. Clin Gastroenterol Hepatol. 2016;14:139-146. [PMID: 26192146 DOI: 10.1016/j.cgh.2015.07.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
315 Muratori P, Granito A, Quarneti C, Ferri S, Menichella R, Cassani F, Pappas G, Bianchi FB, Lenzi M, Muratori L. Autoimmune hepatitis in Italy: the Bologna experience. J Hepatol. 2009;50:1210-1218. [PMID: 19395113 DOI: 10.1016/j.jhep.2009.01.020] [Cited by in Crossref: 84] [Cited by in F6Publishing: 73] [Article Influence: 7.0] [Reference Citation Analysis]
316 Gupta P, Hart J, Millis JM, Cronin D, Brady L. De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation. Transplantation. 2001;71:664-668. [PMID: 11292299 DOI: 10.1097/00007890-200103150-00016] [Cited by in Crossref: 98] [Cited by in F6Publishing: 80] [Article Influence: 4.9] [Reference Citation Analysis]
317 Grant CR, Liberal R. Liver immunology: How to reconcile tolerance with autoimmunity. Clinics and Research in Hepatology and Gastroenterology 2017;41:6-16. [DOI: 10.1016/j.clinre.2016.06.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
318 Heneghan MA, McFarlane IG. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology. 2002;35:7-13. [PMID: 11786954 DOI: 10.1053/jhep.2002.30991] [Cited by in Crossref: 142] [Cited by in F6Publishing: 110] [Article Influence: 7.5] [Reference Citation Analysis]
319 Sokollik C, Mclin VA, Vergani D, Terziroli Beretta-piccoli B, Mieli-vergani G. Juvenile autoimmune hepatitis: A comprehensive review. Journal of Autoimmunity 2018;95:69-76. [DOI: 10.1016/j.jaut.2018.10.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]